134 related articles for article (PubMed ID: 31370746)
1. Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study.
Balaeva T; Grjibovski AM; Samodova O; Sannikov A; Klouman E
Int J Circumpolar Health; 2019 Dec; 78(1):1648970. PubMed ID: 31370746
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in Arkhangelsk, Northwest Russia: a population-based cross-sectional study.
Balaeva T; Grjibovski AM; Sidorenkov O; Samodova O; Firsova N; Sannikov A; Klouman E
BMC Infect Dis; 2016 Oct; 16(1):616. PubMed ID: 27793121
[TBL] [Abstract][Full Text] [Related]
3. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
Aisyah DN; Shallcross L; Hayward A; Aldridge RW; Hemming S; Yates S; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
J Viral Hepat; 2018 Nov; 25(11):1260-1269. PubMed ID: 29851232
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of Markers of Hepatitis B Virus Infection, Associated Factors, and Vaccination Status in Young Adults in Arkhangelsk, Northwest Russia: A Population-Based Cross-Sectional Study.
Balaeva T; Grjibovski AM; Samodova O; Sannikov A; Klouman E
Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200487
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of hepatitis C and correlates of seropositivity among men who have sex with men in Vancouver, Canada: a cross-sectional survey.
Wong J; Moore D; Kanters S; Buxton J; Robert W; Gustafson R; Hogg R; Ogunnaike-Cooke S; Wong T; Gilbert M;
Sex Transm Infect; 2015 Sep; 91(6):430-3. PubMed ID: 25872512
[TBL] [Abstract][Full Text] [Related]
8. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
Rosińska M; Sierosławski J; Wiessing L
BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
[TBL] [Abstract][Full Text] [Related]
9. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.
Neaigus A; Gyarmathy VA; Miller M; Frajzyngier V; Zhao M; Friedman SR; Des Jarlais DC
Drug Alcohol Depend; 2007 Jul; 89(2-3):234-43. PubMed ID: 17289298
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006.
Ghazaryan L; Smith L; Parker M; Flanigan C; Pulver W; Sullivan T; Carrascal A
Matern Child Health J; 2016 Mar; 20(3):550-5. PubMed ID: 26520159
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
[TBL] [Abstract][Full Text] [Related]
14. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis C virus in the general population of northwest Tanzania.
Tess BH; Levin A; Brubaker G; Shao J; Drummond JE; Alter HJ; O'Brien TR
Am J Trop Med Hyg; 2000 Jan; 62(1):138-41. PubMed ID: 10761739
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study.
Acikgoz A; Cimrin D; Kizildag S; Esen N; Balci P; Sayiner AA
BMC Infect Dis; 2020 Jul; 20(1):529. PubMed ID: 32698841
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.
Winslow M; Subramaniam M; Ng WL; Lee A; Song G; Chan YH
Singapore Med J; 2007 Jun; 48(6):504-8. PubMed ID: 17538746
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus seroprevalence in the Netherlands.
Vriend HJ; Op de Coul EL; van de Laar TJ; Urbanus AT; van der Klis FR; Boot HJ
Eur J Public Health; 2012 Dec; 22(6):819-21. PubMed ID: 22461704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
